Results 11 to 20 of about 2,528,348 (198)

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans [PDF]

open access: yes, 2013
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP).
Both, L   +26 more
core   +1 more source

IgG Fc engineering to modulate antibody effector functions

open access: yesProtein & Cell, 2017
Therapeutic monoclonal antibodies are among the most effective biotherapeutics to date. An important aspect of antibodies is their ability to bind antigen while at the same time recruit immune effector functions.
Xinhua Wang   +2 more
doaj   +1 more source

Authorship Weightage Algorithm for Academic Publications: A New Calculation and ACES Webserver for Determining Expertise

open access: yesMethods and Protocols, 2021
Despite the public availability, finding experts in any field when relying on academic publications can be challenging, especially with the use of jargons.
Wei-Ling Wu   +5 more
doaj   +1 more source

Monoclonal Antibody-Directed Therapy [PDF]

open access: yes, 2022
The book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as challenges and opportunities, next-generation antibody products, Antibody-Drug-Conjugates (ADC), bispecifics, glycosylation, and T-cell engagers are covered.

core   +1 more source

An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice

open access: yesFrontiers in Microbiology, 2023
Instruction: Rift valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that causes severe disease in animals and humans. Nevertheless, there are no vaccines applied to prevent RVFV infection for human at present.
Meng Hao   +10 more
doaj   +1 more source

The Role of Antibody-Based Therapies in Neuro-Oncology [PDF]

open access: yes, 2023
This review explores the evolving landscape of antibody-based therapies in neuro-oncology, in particular, immune checkpoint inhibitors and immunomodulatory antibodies.
Jing Sun   +9 more
core   +1 more source

Challenges and developments in universal vaccine design against SARS-CoV-2 variants

open access: yesnpj Vaccines, 2022
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had become a global concern because of its unexpectedly high pathogenicity and transmissibility.
Fangxin Zhao   +4 more
doaj   +1 more source

Antibodies and antibody-derived analytical biosensors [PDF]

open access: yesEssays in Biochemistry, 2016
The rapid diagnosis of many diseases and timely initiation of appropriate treatment are critical determinants that promote optimal clinical outcomes and general public health. Biosensors are now being applied for rapid diagnostics due to their capacity for point-of-care use with minimum need for operator input.
Sharma, Shikha   +2 more
openaire   +2 more sources

Antibody Conjugation and Formulation [PDF]

open access: yes, 2019
In an era where ultra-high antibody concentrations, high viscosities, low volumes, auto-injectors, and long storage requirements are already complex problems with the current unconjugated monoclonal antibodies on the market the formulation demands for ...
Alves, Nathan J.
core   +1 more source

A comprehensive proteogenomic study of the human Brucella vaccine strain 104 M

open access: yesBMC Genomics, 2017
Background Brucella spp. are Gram-negative, facultative intracellular pathogens that cause brucellosis in both humans and animals. The B. abortus vaccine strain 104 M is the only vaccine available in China for the prevention of brucellosis in humans ...
Xiaodong Zai   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy